20
Jul
2010
02
Jul
2010
06
May
2010
Posted in I - Series C, Q - 2Q10, R - SOUTH EAST, X - Device (Ophthalmology), XX - NC
TearScience (Morrisville, NC) a clinical-stage medical device company focused on the treatment of chronic evaporative dry eye due to obstructive Meibomian Gland Dysfunction, closed a $44.5M Series C financing. Participants include Essex Woodlands Health Ventures, Investor Growth Capital, General Catalyst, De Novo Ventures, Spray Ventures and Quaker Bio Ventures.
24
Jun
2009
23
Jun
2009
Posted in I - Series B, Q - 2Q09, R - WEST, X - Device (Ophthalmology), XX - CA
Transcend Medical (Menlo Park, CA) a research and development stage medical device company focused on minimally invasisve treatment of glaucoma, closed a $35M Series B financing. Participants include HLM Venture Partners, Canaan Partners, Latterell Venture Partners, Technology Partners, Morgenthaler Ventures and Split Rock Partners.
09
Jun
2009
Posted in I - Series A, Q - 2Q09, R - WEST, X - Device (Ophthalmology), XX - CA
Opthonix (Vista, CA) a commercial-stage medical device company providing high definition vision correction lenses addressing eye-to-eye variation, closed a $25.9M Series A financing. Participants include Kleiner Perkins, Enterprise Partners, DAG Ventures, Gund Investment Corp, InterWest Partners, Trex Enterprises and Wasatch Advisors.
31
Mar
2009
30
Mar
2009
Posted in I - Series D, Q - 1Q09, R - WEST, X - Device (Ophthalmology), XX - CA
NeoVista (Fremont, CA) a clinical-stage device company focused on epimacular beta radiation for the treatment of wet age-related macular degeneration, closed a $18M Series D financing. Participants include Essex Woodlands Health Ventures, MPM Capital, Versant Ventures, SV Life Sciences, Carlyle Group and Accuitive Medical Ventures.
01
Dec
2008
Glaukos Corporation (Laguna Hills, CA) a development-stage device company focused on the treatment of glaucoma, closed a $35M Series D financing. Participants include OrbiMed Advisors, Frazier Healthcare Ventures, InterWest Partners, Domain Associates, Fjord Ventures, Montreaux Equity Partners and Versant Ventures.
01
Dec
2008